SGS Quay Pharma

SGS Quay Pharma is a contract development and manufacturing organisation providing formulation development, analytical services, and clinical trial manufacturing for pharmaceutical and biotechnology companies.

The company specialises in dosage form design for APIs with challenging solubility and bioavailability profiles, and in modified and controlled release formulations.

Operating from a MHRA and FDA-approved facility in North Wales, it supports clients from preclinical stage through to Phase III and commercial manufacture.